US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

250.40

-17.9900-6.70%

Pre-market: 252.582.18+0.87%06:50 EDT

Volume:325.61K

Turnover:81.61M

Market Cap:494.41M

PE:- -

High:267.90

Open:266.14

Low:243.24

Close:268.39

52wk High:341.93

52wk Low:76.29

Shares:1.97M

Float Shares:1.97M

Volume Ratio:1.30

T/O Rate:16.49%

Dividend:1.00

Dividend Rate:0.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Rocket Pharma Shares Climb Premarket After FDA Supports Continuation of Trial

Cogent Biosciences reports FDA acceptance of bezuclastinib new drug application

Waystar Rises Over 16% Pre-Market as Report Says Healthcare Software Company Exploring Options Including Sale

Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) for Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Molina Healthcare (MOH), High Tide (HITI) and Cullinan Management (CGEM)

Rocket Pharmaceuticals Says FDA Confirms Path to Complete Phase 2 Danon Disease Trial

MT Newswires Live

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)

Ocular Therapeutix completes pre-NDA meeting with FDA for Axpaxli

Analysts Offer Insights on Healthcare Companies: Benitec Biopharma (BNTC), CVS Health (CVS) and BioNTech SE (BNTX)

Analysts Offer Insights on Healthcare Companies: Cellectis SA (CLLS) and ArriVent BioPharma, Inc. (AVBP)

Aurobindo Pharma Gets US FDA Nod for Inhaler Manufacturing, Marketing

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: CytoMed Therapeutics Limited (GDTC) and Roche Holding AG (OtherRHHVF)

PharmaNutra Buy Rating Reaffirmed as Strong H1 Performance and Global Expansion Underpin Record-Year Outlook with Unchanged Price Target

Barclays downgrades Scholar Rock on valuation after FDA approval

Worldwide Healthcare Trust to Publish August 2026 Monthly Fact Sheet

Health Care Roundup: Market Talk

Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY), Tonix Pharma (TNXP) and Solventum Corporation (SOLV)

Wall Street Analysts Are Bullish on Top Healthcare Picks

Shares of ALEBUND-B Surge Over 17% in Afternoon Trading on US FDA Approval for IgA Nephropathy Drug Candidate

Caliway's Abdominal Fat Reduction Drug Clears US FDA Review

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/LABU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":250.4,"timestamp":1789502400000,"preClose":268.39,"halted":0,"volume":325606,"hourTrading":{"tag":"盘前","latestPrice":252.58,"preClose":250.4,"latestTime":"06:50 EDT","volume":1666,"amount":420661.8346,"timestamp":1789555815425,"change":2.18,"changeRate":0.008706,"amplitude":0.007588},"delay":0,"changeRate":-0.0670293230001117,"floatShares":1974486,"shares":1974486,"eps":0,"marketStatus":"Pre-Mkt","change":-17.99,"latestTime":"09-16 06:50:49 EDT","open":266.14,"high":267.9,"low":243.2444,"amount":81609965.98544,"amplitude":0.091865,"askPrice":252.63,"askSize":2,"bidPrice":252,"bidSize":1,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":250.4,"sharesOutstanding":3074486,"nav":268.659,"aum":530464172.89,"dividendRate":0.004,"bidAskSpread":0.003539,"preHourTrading":{"tag":"盘前","latestPrice":252.58,"preClose":250.4,"latestTime":"06:50 EDT","volume":1666,"amount":420661.8346,"timestamp":1789555815425,"change":2.18,"changeRate":0.008706,"amplitude":0.007588},"postHourTrading":{"tag":"盘后","latestPrice":251.98,"preClose":250.4,"latestTime":"19:59 EDT","volume":8108,"amount":2036460.6035,"timestamp":1789516773600,"change":1.58,"changeRate":0.00631,"amplitude":0.00631},"volumeRatio":1.2973187913517363,"impliedVol":0.9273,"impliedVolPercentile":0.568},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1974486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.2973187913517363,"shares":1974486,"dividePrice":1.0016,"high":267.9,"amplitude":0.091865,"preClose":268.39,"low":243.2444,"week52Low":76.29,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":250.4,"committee":-0.333333,"eps":0,"divideRate":0.004,"volume":325606,"delay":0,"ttmEps":0,"open":266.14,"prevYearClose":159.39,"prevWeekClose":261.3,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":293.07,"twentyDayClose":287.3,"sixtyDayClose":206.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667642146","title":"Rocket Pharma Shares Climb Premarket After FDA Supports Continuation of Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667642146","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667642146?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:19","pubTimestamp":1789474740,"startTime":"0","endTime":"0","summary":"Rocket Pharmaceuticals' shares jumped ahead of the opening bell after the biotechnology company said it was aligned with the Food and Drug Administration on the path forward for its pivotal phase 2 tr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RCKT","BK4139","LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667264291","title":"Cogent Biosciences reports FDA acceptance of bezuclastinib new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667264291","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667264291?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:10","pubTimestamp":1789474252,"startTime":"0","endTime":"0","summary":"Cogent Biosciences (COGT) announced that the FDA has accepted its new drug application for bezuclastinib in patients with Advanced Systemic Mastocy...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cogent-biosciences-reports-fda-acceptance-of-bezuclastinib-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cogent-biosciences-reports-fda-acceptance-of-bezuclastinib-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","BK4532","LABU","LFSC","CCOI","LU1670627923.USD","LU1670628061.USD","BK4588","CANC","BK4505","BK4089","COGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667120642","title":"Waystar Rises Over 16% Pre-Market as Report Says Healthcare Software Company Exploring Options Including Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2667120642","media":"TradingKey","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667120642?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:01","pubTimestamp":1789473708,"startTime":"0","endTime":"0","summary":"TradingKey - On September 15 ET, shares of healthcare software company Waystar (WAY) rose more than 16% at one point in pre-market trading.","market":"us","thumbnail":"https://resource.tradingkey.com/uploads/20260915/way-ed88a225d5a64f4c80b8b10fa1df2086.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260915/way-ed88a225d5a64f4c80b8b10fa1df2086.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262168582-waystar-way-us-ipo-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LU0128526141.USD","LU2089283258.USD","LU1074936037.SGD","BK4588","BK4516","LU1169590202.USD","LU1244550221.USD","LU1162221912.USD","LU1244550494.USD","LU2023251221.USD","LU2357305700.SGD","LU0557290698.USD","LU1989772923.USD","LU0225283273.USD","LU2264538146.SGD","LU0882574139.USD","IE00B775SV38.USD","LU2347655156.SGD","LU0106831901.USD","IE00B3S45H60.SGD","LU0053666078.USD","BK4504","LU1988902786.USD","KBWB","LU0267386448.USD","LU2111349929.HKD","LU1732799900.SGD","LU0098860793.USD","LU2133065610.SGD","HCSG","QQH","LU0390134368.USD","LU0528227936.USD","LU1064131342.USD","XLV","LU0158827948.USD","BK4585","IAI","WAY","LABU","LU1720051017.SGD","BK4534","LU1668664300.SGD","LU0971096721.USD","LU2487616109.SGD","LU1548497426.USD","BK4127","LU2089284900.SGD","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667422886","title":"Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) for Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667422886","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667422886?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:00","pubTimestamp":1789473600,"startTime":"0","endTime":"0","summary":"NDA supported by positive results from the APEX pivotal trial demonstrating clinically meaningful responses and evidence of disease modification in patients with AdvSM PDUFA target action date set for","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/15/3361988/0/en/cogent-biosciences-announces-fda-acceptance-of-new-drug-application-nda-for-bezuclastinib-in-patients-with-advanced-systemic-mastocytosis-advsm.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2931357623.SGD","LABU","BK4585","BK4532","AEIS","LU1815336091.USD","IE0031619046.USD","IE00B66KJ199.SGD","LU2089985449.USD","IE00B7SZL793.SGD","LU1670627923.USD","IE00B19Z4B17.USD","CCOI","LU1670628061.USD","LU0757428866.USD","BK4588","BK4089","LU0274383776.USD","BK4157"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667644374","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Molina Healthcare (MOH), High Tide (HITI) and Cullinan Management (CGEM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644374","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667644374?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:40","pubTimestamp":1789472436,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Molina Healthcare (MOH), High Tide (HITI) and Cull...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-molina-healthcare-moh-high-tide-hiti-and-cullinan-management-cgem-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-molina-healthcare-moh-high-tide-hiti-and-cullinan-management-cgem-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","BK4581","BK4532","CGEM","LABU","MOH","SG9999014013.SGD","XBI","SG9999014039.USD","BK4588","BK4154","BK4007","PSCH","SG9999014005.SGD","XLV","HITI","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667337644","title":"Rocket Pharmaceuticals Says FDA Confirms Path to Complete Phase 2 Danon Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2667337644","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667337644?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:39","pubTimestamp":1789472373,"startTime":"0","endTime":"0","summary":"Rocket Pharmaceuticals  said Tuesday that it is aligned with the US Food and Drug Administration, or FDA, as it completes its phase 2 trial evaluating RP-A501 to treat Danon disease.The company said that the FDA reviewed data from the first three patients treated under a modified protocol and confirmed continued enrollment of 12 patients dosed at the recalibrated dose.The pivotal study will include 12 male patients, with the first three treated under the modified protocol counting toward the total. Rocket expects to enroll and dose the remaining nine patients by mid-2027.Rocket said it will conduct a primary assessment at 12 months using previously established co-primary endpoints of myocardial LAMP2 protein expression and a 10% reduction from baseline in left ventricular mass index.Shares of the company were up 9% in Tuesday's premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","RCKT.AU","LABU","BK4588","RCKT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667641173","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667641173","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667641173?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:20","pubTimestamp":1789471221,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Centene (CNC), Natera (NTRA) and Vertex Pharmaceut...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-centene-cnc-natera-ntra-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-centene-cnc-natera-ntra-and-vertex-pharmaceuticals-vrtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","LU0053671581.USD","BK4585","LU1035775433.USD","XLV","NTRA","LU0859254822.USD","CNC","LU0130518102.USD","GNMX","IBBQ","LU1291159041.SGD","HCSG","IE0002270589.USD","LU1988902786.USD","PBE","BK4023","LU0289739699.SGD","CNCG","LU0648000940.SGD","LU0823416689.USD","LU2065171311.SGD","TBXU","VRTX","BK4567","LABU","BK4139","IE0009355771.USD","IE00B19Z3581.USD","LU2236285917.USD","LU2462157665.USD","HELX","VERX","BK4137","LU1430594728.SGD","XBI","BK4581","IBB","IE00B19Z9Z06.USD","BIB","LU0234570918.USD","GNOM","LU1674673691.USD","LU0128526141.USD","BBH","LU0012050646.USD","LU2456880835.USD","LU1585245621.USD","LU2065169927.USD","BK4154"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667121641","title":"Ocular Therapeutix completes pre-NDA meeting with FDA for Axpaxli","url":"https://stock-news.laohu8.com/highlight/detail?id=2667121641","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667121641?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:15","pubTimestamp":1789470920,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix (OCUL) announced the completion of its pre-new drug application, or NDA, meeting with the FDA for its investigational product ca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ocular-therapeutix-completes-pre-nda-meeting-with-fda-for-axpaxli-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ocular-therapeutix-completes-pre-nda-meeting-with-fda-for-axpaxli-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","OCUL","BK4007","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667264114","title":"Analysts Offer Insights on Healthcare Companies: Benitec Biopharma (BNTC), CVS Health (CVS) and BioNTech SE (BNTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667264114","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667264114?lang=en_us&edition=fundamental","pubTime":"2026-09-15 19:10","pubTimestamp":1789470613,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Benitec Biopharma (BNTC), CVS Health (CVS) and BioNT...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-benitec-biopharma-bntc-cvs-health-cvs-and-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-benitec-biopharma-bntc-cvs-health-cvs-and-biontech-se-bntx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1059921491.USD","IHF","LU0072461881.USD","LU2357627491.SGD","IE00BSNM7G36.USD","LU0029874061.USD","LU0208291251.USD","BK4550","LU0432979614.USD","LU0211331839.USD","BNTX","IE00B7SZLL34.SGD","XBI","LU0128526141.USD","LU0162691827.USD","IE0002270589.USD","HCSG","BK4568","IE00B19Z3581.USD","LU0320765489.SGD","IE00B19Z3B42.SGD","BK4588","BK4137","IE00BZ1G4Q59.USD","LU1923622614.USD","LU2125909593.SGD","BK4551","LU0006061336.USD","LU1571399168.USD","BK4585","BK4548","LU0859254822.USD","LU2125909247.SGD","LU1983299246.USD","BK4581","BK4535","LU1699723380.USD","BNTC","BK4139","RTH","LU0061475181.USD","LU2433249047.HKD","LU1236620750.USD","BK4504","IE00BKVL7J92.USD","LABU","XLV","BK4196","LU0070302665.USD","CVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667703649","title":"Analysts Offer Insights on Healthcare Companies: Cellectis SA (CLLS) and ArriVent BioPharma, Inc. (AVBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667703649","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667703649?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:50","pubTimestamp":1789469407,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cellectis SA (CLLS) and ArriVent BioPharma, Inc. (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cellectis-sa-clls-and-arrivent-biopharma-inc-avbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cellectis-sa-clls-and-arrivent-biopharma-inc-avbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVBP","BK4139","LABU","LU0128526141.USD","BK4585","BK4137","LU0029874061.USD","XBI","HCSG","XLV","BK4581","CLLS","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667461846","title":"Aurobindo Pharma Gets US FDA Nod for Inhaler Manufacturing, Marketing","url":"https://stock-news.laohu8.com/highlight/detail?id=2667461846","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667461846?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:23","pubTimestamp":1789467834,"startTime":"0","endTime":"0","summary":"Aurobindo Pharma (NSE:AUROPHARMA, BOM:524804) obtained approval from the US Food & Drug Administration (FDA) to manufacture and market Beclomethasone Dipropionate HFA Inhalation Aerosol.This is the company's first metered-dose inhaler product, according to a Tuesday Indian bourse filing.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667864699","title":"Analysts Offer Insights on Healthcare Companies: CytoMed Therapeutics Limited (GDTC) and Roche Holding AG (OtherRHHVF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667864699","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667864699?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:20","pubTimestamp":1789467606,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on CytoMed Therapeutics Limited (GDTC) and Roche Holding AG (RHHVF)....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cytomed-therapeutics-limited-gdtc-and-roche-holding-ag-otherrhhvf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cytomed-therapeutics-limited-gdtc-and-roche-holding-ag-otherrhhvf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","HCSG","RHHVF","XBI","LU0029874061.USD","BK4581","LU2539964713.USD","BK4588","LU2293690082.USD","XLV","LU0128526141.USD","LU1046234339.USD","LU2293690249.USD","BK4137","LABU","GDTC","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667645236","title":"PharmaNutra Buy Rating Reaffirmed as Strong H1 Performance and Global Expansion Underpin Record-Year Outlook with Unchanged Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2667645236","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667645236?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:45","pubTimestamp":1789465518,"startTime":"0","endTime":"0","summary":"PharmaNutra SpA, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Corentin Marty from TP ICAP MIDCAP reiter...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/pharmanutra-buy-rating-reaffirmed-as-strong-h1-performance-and-global-expansion-underpin-record-year-outlook-with-unchanged-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/pharmanutra-buy-rating-reaffirmed-as-strong-h1-performance-and-global-expansion-underpin-record-year-outlook-with-unchanged-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","BK4581","TP","ICAP","XBI","BK4588","XLV","BK4108"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667643557","title":"Barclays downgrades Scholar Rock on valuation after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667643557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667643557?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:10","pubTimestamp":1789463419,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout downgraded Scholar Rock (SRRK) to Equal Weight from Overweight with a price target of $58, up from $55. The approval ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/barclays-downgrades-scholar-rock-on-valuation-after-fda-approval-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CDIG","IBB","TACU","LFSC","FRTY","PINK","SYNB","TBXU","TSPA","TECB","LABU","PSCH","GNMX","MEDI","BBP","RSPH","MRNY","BMED","IYH","XLVX","IDNA","GDOC","NVIB","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667610402","title":"Worldwide Healthcare Trust to Publish August 2026 Monthly Fact Sheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2667610402","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667610402?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:22","pubTimestamp":1789460560,"startTime":"0","endTime":"0","summary":"Worldwide Healthcare Trust PLC GBP ( ($GB:WWH) ) has shared an update. Worldwide Healthcare Trust PLC has announced that its monthly fact sheet for...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-to-publish-august-2026-monthly-fact-sheet?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-to-publish-august-2026-monthly-fact-sheet?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","HCSG","LABU","LU0128526141.USD","LU0029874061.USD","BK4137","BK4585","BK4581","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667361032","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2667361032","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667361032?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:20","pubTimestamp":1789460400,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0731 GMT - Medacta should continue to book above-market growth r","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","XBI","BK4581","BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667130617","title":"Analysts Offer Insights on Healthcare Companies: Butterfly Network (BFLY), Tonix Pharma (TNXP) and Solventum Corporation (SOLV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667130617","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667130617?lang=en_us&edition=fundamental","pubTime":"2026-09-15 16:00","pubTimestamp":1789459250,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Butterfly Network (BFLY), Tonix Pharma (TNXP) and So...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-butterfly-network-bfly-tonix-pharma-tnxp-and-solventum-corporation-solv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-butterfly-network-bfly-tonix-pharma-tnxp-and-solventum-corporation-solv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XBI","BK4198","BK4137","BK4581","BK4583","LU0128526141.USD","LABU","TNXP","BK4588","HCSG","SOLV","BK4139","BK4082","XLV","BFLY","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667612762","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2667612762","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667612762?lang=en_us&edition=fundamental","pubTime":"2026-09-15 15:30","pubTimestamp":1789457409,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Telix Pharmaceuticals (TLPPF) and LeonaBio (LONA) wi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-338?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-338?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","LONA","HCSG","BK4139","TLPPF","XBI","XLV","LU0029874061.USD","BK4588","LABU","BK4585","TLX","BK4137","BK4007","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151094926","title":"Shares of ALEBUND-B Surge Over 17% in Afternoon Trading on US FDA Approval for IgA Nephropathy Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1151094926","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151094926?lang=en_us&edition=fundamental","pubTime":"2026-09-15 13:58","pubTimestamp":1789451896,"startTime":"0","endTime":"0","summary":"Shares of ALEBUND-B (09637) rallied sharply in the afternoon, climbing more than 17% at one point. At the time of writing, the stock was up 12.96% to HK$25.98, with turnover reaching HK$36.28...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LABU","09637","BK4588","BK1191","159938","VXUS","09939","BK1574","BK4585","BK1515","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667816616","title":"Caliway's Abdominal Fat Reduction Drug Clears US FDA Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2667816616","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667816616?lang=en_us&edition=fundamental","pubTime":"2026-09-15 13:05","pubTimestamp":1789448708,"startTime":"0","endTime":"0","summary":"Caliway Biopharmaceuticals  said the U.S. FDA's 30-day review period for an amended Phase 3 protocol for CBL-514 in abdominal subcutaneous fat reduction has been cleared.The SUPREME-02 study will enroll about 320 participants and assess CBL-514's safety and effectiveness in reducing abdominal fat, according to a Monday filing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":22,"pageCount":3,"totalSize":425,"code":"91000000","status":"200"}]}}